nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—ABCB1—lung cancer	0.176	1	CbGaD
Fentanyl—CYP3A5—Gefitinib—lung cancer	0.0307	0.0581	CbGbCtD
Fentanyl—CYP3A5—Teniposide—lung cancer	0.0298	0.0563	CbGbCtD
Fentanyl—CYP3A7—Paclitaxel—lung cancer	0.0222	0.0419	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0222	0.0419	CbGbCtD
Fentanyl—CYP3A7—Irinotecan—lung cancer	0.0219	0.0414	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0219	0.0414	CbGbCtD
Fentanyl—ABCB1—Topotecan—lung cancer	0.0218	0.0413	CbGbCtD
Fentanyl—ABCB1—Gefitinib—lung cancer	0.02	0.0378	CbGbCtD
Fentanyl—CYP3A5—Crizotinib—lung cancer	0.0188	0.0356	CbGbCtD
Fentanyl—CYP3A5—Erlotinib—lung cancer	0.0182	0.0344	CbGbCtD
Fentanyl—CYP3A5—Paclitaxel—lung cancer	0.0166	0.0314	CbGbCtD
Fentanyl—CYP3A5—Irinotecan—lung cancer	0.0164	0.031	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.016	0.0303	CbGbCtD
Fentanyl—CYP3A7—Docetaxel—lung cancer	0.016	0.0303	CbGbCtD
Fentanyl—ABCB1—Vinorelbine—lung cancer	0.0154	0.0291	CbGbCtD
Fentanyl—CYP3A5—Etoposide—lung cancer	0.0131	0.0248	CbGbCtD
Fentanyl—CYP3A4—Topotecan—lung cancer	0.0131	0.0248	CbGbCtD
Fentanyl—ABCB1—Crizotinib—lung cancer	0.0122	0.0232	CbGbCtD
Fentanyl—CYP3A5—Docetaxel—lung cancer	0.012	0.0227	CbGbCtD
Fentanyl—CYP3A4—Gefitinib—lung cancer	0.012	0.0227	CbGbCtD
Fentanyl—ABCB1—Gemcitabine—lung cancer	0.012	0.0227	CbGbCtD
Fentanyl—ABCB1—Erlotinib—lung cancer	0.0118	0.0224	CbGbCtD
Fentanyl—CYP3A4—Teniposide—lung cancer	0.0116	0.022	CbGbCtD
Fentanyl—ABCB1—Paclitaxel—lung cancer	0.0108	0.0205	CbGbCtD
Fentanyl—ABCB1—Irinotecan—lung cancer	0.0107	0.0202	CbGbCtD
Fentanyl—ABCB1—Vinblastine—lung cancer	0.00949	0.018	CbGbCtD
Fentanyl—CYP3A4—Vinorelbine—lung cancer	0.00922	0.0175	CbGbCtD
Fentanyl—ABCB1—Cisplatin—lung cancer	0.0087	0.0165	CbGbCtD
Fentanyl—ABCB1—Etoposide—lung cancer	0.00855	0.0162	CbGbCtD
Fentanyl—ABCB1—Docetaxel—lung cancer	0.00782	0.0148	CbGbCtD
Fentanyl—CYP3A4—Crizotinib—lung cancer	0.00734	0.0139	CbGbCtD
Fentanyl—CYP3A4—Erlotinib—lung cancer	0.00708	0.0134	CbGbCtD
Fentanyl—CYP3A4—Paclitaxel—lung cancer	0.00648	0.0123	CbGbCtD
Fentanyl—CYP3A4—Irinotecan—lung cancer	0.00639	0.0121	CbGbCtD
Fentanyl—ABCB1—Doxorubicin—lung cancer	0.00583	0.011	CbGbCtD
Fentanyl—CYP3A4—Vinblastine—lung cancer	0.00568	0.0108	CbGbCtD
Fentanyl—ABCB1—Methotrexate—lung cancer	0.00565	0.0107	CbGbCtD
Fentanyl—CYP3A4—Etoposide—lung cancer	0.00512	0.00969	CbGbCtD
Fentanyl—CYP3A4—Docetaxel—lung cancer	0.00468	0.00887	CbGbCtD
Fentanyl—CYP3A4—Doxorubicin—lung cancer	0.00349	0.00661	CbGbCtD
Fentanyl—Trimethaphan—CHRNB4—lung cancer	0.0013	0.351	CrCbGaD
Fentanyl—Trimethaphan—CHRNA3—lung cancer	0.000901	0.243	CrCbGaD
Fentanyl—Loperamide—POMC—lung cancer	0.000534	0.144	CrCbGaD
Fentanyl—Alfentanil—ALB—lung cancer	0.000189	0.051	CrCbGaD
Fentanyl—Alfentanil—ABCB1—lung cancer	0.00018	0.0487	CrCbGaD
Fentanyl—Astemizole—ABCB1—lung cancer	0.00014	0.0379	CrCbGaD
Fentanyl—Phenylbutazone—PTGS2—lung cancer	0.000101	0.0274	CrCbGaD
Fentanyl—Fexofenadine—ABCB1—lung cancer	0.0001	0.027	CrCbGaD
Fentanyl—Propafenone—ABCB1—lung cancer	8.06e-05	0.0217	CrCbGaD
Fentanyl—Bepridil—ABCB1—lung cancer	7.18e-05	0.0194	CrCbGaD
Fentanyl—Loperamide—ABCB1—lung cancer	6.36e-05	0.0172	CrCbGaD
Fentanyl—Methadone—ABCB1—lung cancer	4.53e-05	0.0122	CrCbGaD
Fentanyl—Feeling abnormal—Etoposide—lung cancer	4.12e-05	0.000175	CcSEcCtD
Fentanyl—Hyperglycaemia—Doxorubicin—lung cancer	4.12e-05	0.000175	CcSEcCtD
Fentanyl—Diarrhoea—Irinotecan—lung cancer	4.12e-05	0.000175	CcSEcCtD
Fentanyl—Pneumonia—Doxorubicin—lung cancer	4.09e-05	0.000174	CcSEcCtD
Fentanyl—Gastrointestinal pain—Etoposide—lung cancer	4.09e-05	0.000174	CcSEcCtD
Fentanyl—Shock—Docetaxel—lung cancer	4.09e-05	0.000174	CcSEcCtD
Fentanyl—Nervous system disorder—Docetaxel—lung cancer	4.08e-05	0.000173	CcSEcCtD
Fentanyl—Thrombocytopenia—Docetaxel—lung cancer	4.07e-05	0.000173	CcSEcCtD
Fentanyl—Drowsiness—Doxorubicin—lung cancer	4.07e-05	0.000173	CcSEcCtD
Fentanyl—Infestation—Doxorubicin—lung cancer	4.07e-05	0.000173	CcSEcCtD
Fentanyl—Infestation NOS—Doxorubicin—lung cancer	4.07e-05	0.000173	CcSEcCtD
Fentanyl—Visual impairment—Methotrexate—lung cancer	4.07e-05	0.000172	CcSEcCtD
Fentanyl—Tachycardia—Docetaxel—lung cancer	4.06e-05	0.000172	CcSEcCtD
Fentanyl—Feeling abnormal—Paclitaxel—lung cancer	4.04e-05	0.000171	CcSEcCtD
Fentanyl—Skin disorder—Docetaxel—lung cancer	4.04e-05	0.000171	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Doxorubicin—lung cancer	4.04e-05	0.000171	CcSEcCtD
Fentanyl—Hypersensitivity—Cisplatin—lung cancer	4.03e-05	0.000171	CcSEcCtD
Fentanyl—Gastrointestinal pain—Paclitaxel—lung cancer	4.01e-05	0.00017	CcSEcCtD
Fentanyl—Diarrhoea—Gemcitabine—lung cancer	4.01e-05	0.00017	CcSEcCtD
Fentanyl—Renal failure—Doxorubicin—lung cancer	4e-05	0.00017	CcSEcCtD
Fentanyl—Erythema multiforme—Methotrexate—lung cancer	3.99e-05	0.000169	CcSEcCtD
Fentanyl—Neuropathy peripheral—Doxorubicin—lung cancer	3.99e-05	0.000169	CcSEcCtD
Fentanyl—Dizziness—Irinotecan—lung cancer	3.98e-05	0.000169	CcSEcCtD
Fentanyl—Urticaria—Etoposide—lung cancer	3.98e-05	0.000169	CcSEcCtD
Fentanyl—Jaundice—Doxorubicin—lung cancer	3.97e-05	0.000168	CcSEcCtD
Fentanyl—Stomatitis—Doxorubicin—lung cancer	3.97e-05	0.000168	CcSEcCtD
Fentanyl—Anorexia—Docetaxel—lung cancer	3.97e-05	0.000168	CcSEcCtD
Fentanyl—Body temperature increased—Etoposide—lung cancer	3.96e-05	0.000168	CcSEcCtD
Fentanyl—Abdominal pain—Etoposide—lung cancer	3.96e-05	0.000168	CcSEcCtD
Fentanyl—Conjunctivitis—Doxorubicin—lung cancer	3.96e-05	0.000168	CcSEcCtD
Fentanyl—Urinary tract infection—Doxorubicin—lung cancer	3.96e-05	0.000168	CcSEcCtD
Fentanyl—Eye disorder—Methotrexate—lung cancer	3.94e-05	0.000167	CcSEcCtD
Fentanyl—Tinnitus—Methotrexate—lung cancer	3.93e-05	0.000167	CcSEcCtD
Fentanyl—Asthenia—Cisplatin—lung cancer	3.92e-05	0.000166	CcSEcCtD
Fentanyl—Cardiac disorder—Methotrexate—lung cancer	3.92e-05	0.000166	CcSEcCtD
Fentanyl—Sweating—Doxorubicin—lung cancer	3.9e-05	0.000165	CcSEcCtD
Fentanyl—Urticaria—Paclitaxel—lung cancer	3.9e-05	0.000165	CcSEcCtD
Fentanyl—Hypotension—Docetaxel—lung cancer	3.89e-05	0.000165	CcSEcCtD
Fentanyl—Haematuria—Doxorubicin—lung cancer	3.88e-05	0.000165	CcSEcCtD
Fentanyl—Abdominal pain—Paclitaxel—lung cancer	3.88e-05	0.000165	CcSEcCtD
Fentanyl—Body temperature increased—Paclitaxel—lung cancer	3.88e-05	0.000165	CcSEcCtD
Fentanyl—Hepatobiliary disease—Doxorubicin—lung cancer	3.85e-05	0.000163	CcSEcCtD
Fentanyl—Epistaxis—Doxorubicin—lung cancer	3.84e-05	0.000163	CcSEcCtD
Fentanyl—Angiopathy—Methotrexate—lung cancer	3.83e-05	0.000162	CcSEcCtD
Fentanyl—Vomiting—Irinotecan—lung cancer	3.83e-05	0.000162	CcSEcCtD
Fentanyl—Sinusitis—Doxorubicin—lung cancer	3.82e-05	0.000162	CcSEcCtD
Fentanyl—Immune system disorder—Methotrexate—lung cancer	3.81e-05	0.000162	CcSEcCtD
Fentanyl—Mediastinal disorder—Methotrexate—lung cancer	3.8e-05	0.000161	CcSEcCtD
Fentanyl—Rash—Irinotecan—lung cancer	3.79e-05	0.000161	CcSEcCtD
Fentanyl—Dermatitis—Irinotecan—lung cancer	3.79e-05	0.000161	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Docetaxel—lung cancer	3.79e-05	0.000161	CcSEcCtD
Fentanyl—Chills—Methotrexate—lung cancer	3.79e-05	0.000161	CcSEcCtD
Fentanyl—Headache—Irinotecan—lung cancer	3.77e-05	0.00016	CcSEcCtD
Fentanyl—Insomnia—Docetaxel—lung cancer	3.76e-05	0.00016	CcSEcCtD
Fentanyl—Diarrhoea—Cisplatin—lung cancer	3.74e-05	0.000159	CcSEcCtD
Fentanyl—Paraesthesia—Docetaxel—lung cancer	3.74e-05	0.000158	CcSEcCtD
Fentanyl—Alopecia—Methotrexate—lung cancer	3.73e-05	0.000158	CcSEcCtD
Fentanyl—Vomiting—Gemcitabine—lung cancer	3.73e-05	0.000158	CcSEcCtD
Fentanyl—Bradycardia—Doxorubicin—lung cancer	3.72e-05	0.000158	CcSEcCtD
Fentanyl—Dyspnoea—Docetaxel—lung cancer	3.71e-05	0.000157	CcSEcCtD
Fentanyl—Somnolence—Docetaxel—lung cancer	3.7e-05	0.000157	CcSEcCtD
Fentanyl—Mental disorder—Methotrexate—lung cancer	3.7e-05	0.000157	CcSEcCtD
Fentanyl—Rash—Gemcitabine—lung cancer	3.7e-05	0.000157	CcSEcCtD
Fentanyl—Dermatitis—Gemcitabine—lung cancer	3.69e-05	0.000157	CcSEcCtD
Fentanyl—Hypersensitivity—Etoposide—lung cancer	3.69e-05	0.000156	CcSEcCtD
Fentanyl—Malnutrition—Methotrexate—lung cancer	3.67e-05	0.000156	CcSEcCtD
Fentanyl—Erythema—Methotrexate—lung cancer	3.67e-05	0.000156	CcSEcCtD
Fentanyl—Haemoglobin—Doxorubicin—lung cancer	3.67e-05	0.000156	CcSEcCtD
Fentanyl—Headache—Gemcitabine—lung cancer	3.67e-05	0.000156	CcSEcCtD
Fentanyl—Rhinitis—Doxorubicin—lung cancer	3.66e-05	0.000155	CcSEcCtD
Fentanyl—Dyspepsia—Docetaxel—lung cancer	3.66e-05	0.000155	CcSEcCtD
Fentanyl—Haemorrhage—Doxorubicin—lung cancer	3.65e-05	0.000155	CcSEcCtD
Fentanyl—Hypoaesthesia—Doxorubicin—lung cancer	3.64e-05	0.000154	CcSEcCtD
Fentanyl—Pharyngitis—Doxorubicin—lung cancer	3.63e-05	0.000154	CcSEcCtD
Fentanyl—Decreased appetite—Docetaxel—lung cancer	3.62e-05	0.000153	CcSEcCtD
Fentanyl—Hypersensitivity—Paclitaxel—lung cancer	3.62e-05	0.000153	CcSEcCtD
Fentanyl—Urinary tract disorder—Doxorubicin—lung cancer	3.61e-05	0.000153	CcSEcCtD
Fentanyl—Oedema peripheral—Doxorubicin—lung cancer	3.6e-05	0.000153	CcSEcCtD
Fentanyl—Dysgeusia—Methotrexate—lung cancer	3.6e-05	0.000153	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Docetaxel—lung cancer	3.59e-05	0.000152	CcSEcCtD
Fentanyl—Asthenia—Etoposide—lung cancer	3.59e-05	0.000152	CcSEcCtD
Fentanyl—Connective tissue disorder—Doxorubicin—lung cancer	3.59e-05	0.000152	CcSEcCtD
Fentanyl—Fatigue—Docetaxel—lung cancer	3.59e-05	0.000152	CcSEcCtD
Fentanyl—Urethral disorder—Doxorubicin—lung cancer	3.58e-05	0.000152	CcSEcCtD
Fentanyl—Nausea—Irinotecan—lung cancer	3.57e-05	0.000152	CcSEcCtD
Fentanyl—Constipation—Docetaxel—lung cancer	3.56e-05	0.000151	CcSEcCtD
Fentanyl—Pain—Docetaxel—lung cancer	3.56e-05	0.000151	CcSEcCtD
Fentanyl—Back pain—Methotrexate—lung cancer	3.55e-05	0.000151	CcSEcCtD
Fentanyl—Pruritus—Etoposide—lung cancer	3.54e-05	0.00015	CcSEcCtD
Fentanyl—Visual impairment—Doxorubicin—lung cancer	3.52e-05	0.000149	CcSEcCtD
Fentanyl—Asthenia—Paclitaxel—lung cancer	3.52e-05	0.000149	CcSEcCtD
Fentanyl—Nausea—Gemcitabine—lung cancer	3.48e-05	0.000148	CcSEcCtD
Fentanyl—Vomiting—Cisplatin—lung cancer	3.47e-05	0.000147	CcSEcCtD
Fentanyl—Pruritus—Paclitaxel—lung cancer	3.47e-05	0.000147	CcSEcCtD
Fentanyl—Vision blurred—Methotrexate—lung cancer	3.46e-05	0.000147	CcSEcCtD
Fentanyl—Erythema multiforme—Doxorubicin—lung cancer	3.45e-05	0.000147	CcSEcCtD
Fentanyl—Rash—Cisplatin—lung cancer	3.44e-05	0.000146	CcSEcCtD
Fentanyl—Dermatitis—Cisplatin—lung cancer	3.44e-05	0.000146	CcSEcCtD
Fentanyl—Feeling abnormal—Docetaxel—lung cancer	3.43e-05	0.000145	CcSEcCtD
Fentanyl—Diarrhoea—Etoposide—lung cancer	3.42e-05	0.000145	CcSEcCtD
Fentanyl—Eye disorder—Doxorubicin—lung cancer	3.41e-05	0.000145	CcSEcCtD
Fentanyl—Ill-defined disorder—Methotrexate—lung cancer	3.41e-05	0.000145	CcSEcCtD
Fentanyl—Tinnitus—Doxorubicin—lung cancer	3.41e-05	0.000144	CcSEcCtD
Fentanyl—Gastrointestinal pain—Docetaxel—lung cancer	3.4e-05	0.000144	CcSEcCtD
Fentanyl—Anaemia—Methotrexate—lung cancer	3.4e-05	0.000144	CcSEcCtD
Fentanyl—Flushing—Doxorubicin—lung cancer	3.39e-05	0.000144	CcSEcCtD
Fentanyl—Cardiac disorder—Doxorubicin—lung cancer	3.39e-05	0.000144	CcSEcCtD
Fentanyl—Diarrhoea—Paclitaxel—lung cancer	3.36e-05	0.000142	CcSEcCtD
Fentanyl—Angiopathy—Doxorubicin—lung cancer	3.32e-05	0.000141	CcSEcCtD
Fentanyl—Malaise—Methotrexate—lung cancer	3.31e-05	0.00014	CcSEcCtD
Fentanyl—Dizziness—Etoposide—lung cancer	3.31e-05	0.00014	CcSEcCtD
Fentanyl—Immune system disorder—Doxorubicin—lung cancer	3.3e-05	0.00014	CcSEcCtD
Fentanyl—Vertigo—Methotrexate—lung cancer	3.3e-05	0.00014	CcSEcCtD
Fentanyl—Mediastinal disorder—Doxorubicin—lung cancer	3.29e-05	0.00014	CcSEcCtD
Fentanyl—Abdominal pain—Docetaxel—lung cancer	3.29e-05	0.000139	CcSEcCtD
Fentanyl—Body temperature increased—Docetaxel—lung cancer	3.29e-05	0.000139	CcSEcCtD
Fentanyl—Leukopenia—Methotrexate—lung cancer	3.29e-05	0.000139	CcSEcCtD
Fentanyl—Chills—Doxorubicin—lung cancer	3.28e-05	0.000139	CcSEcCtD
Fentanyl—Arrhythmia—Doxorubicin—lung cancer	3.26e-05	0.000138	CcSEcCtD
Fentanyl—Dizziness—Paclitaxel—lung cancer	3.25e-05	0.000138	CcSEcCtD
Fentanyl—Nausea—Cisplatin—lung cancer	3.25e-05	0.000138	CcSEcCtD
Fentanyl—Alopecia—Doxorubicin—lung cancer	3.23e-05	0.000137	CcSEcCtD
Fentanyl—Cough—Methotrexate—lung cancer	3.21e-05	0.000136	CcSEcCtD
Fentanyl—Mental disorder—Doxorubicin—lung cancer	3.2e-05	0.000136	CcSEcCtD
Fentanyl—Convulsion—Methotrexate—lung cancer	3.18e-05	0.000135	CcSEcCtD
Fentanyl—Vomiting—Etoposide—lung cancer	3.18e-05	0.000135	CcSEcCtD
Fentanyl—Erythema—Doxorubicin—lung cancer	3.18e-05	0.000135	CcSEcCtD
Fentanyl—Malnutrition—Doxorubicin—lung cancer	3.18e-05	0.000135	CcSEcCtD
Fentanyl—Rash—Etoposide—lung cancer	3.16e-05	0.000134	CcSEcCtD
Fentanyl—Dermatitis—Etoposide—lung cancer	3.15e-05	0.000134	CcSEcCtD
Fentanyl—Headache—Etoposide—lung cancer	3.14e-05	0.000133	CcSEcCtD
Fentanyl—Flatulence—Doxorubicin—lung cancer	3.13e-05	0.000133	CcSEcCtD
Fentanyl—Arthralgia—Methotrexate—lung cancer	3.13e-05	0.000133	CcSEcCtD
Fentanyl—Myalgia—Methotrexate—lung cancer	3.13e-05	0.000133	CcSEcCtD
Fentanyl—Chest pain—Methotrexate—lung cancer	3.13e-05	0.000133	CcSEcCtD
Fentanyl—Tension—Doxorubicin—lung cancer	3.12e-05	0.000132	CcSEcCtD
Fentanyl—Vomiting—Paclitaxel—lung cancer	3.12e-05	0.000132	CcSEcCtD
Fentanyl—Dysgeusia—Doxorubicin—lung cancer	3.11e-05	0.000132	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.11e-05	0.000132	CcSEcCtD
Fentanyl—Rash—Paclitaxel—lung cancer	3.09e-05	0.000131	CcSEcCtD
Fentanyl—Dermatitis—Paclitaxel—lung cancer	3.09e-05	0.000131	CcSEcCtD
Fentanyl—Discomfort—Methotrexate—lung cancer	3.09e-05	0.000131	CcSEcCtD
Fentanyl—Nervousness—Doxorubicin—lung cancer	3.09e-05	0.000131	CcSEcCtD
Fentanyl—Back pain—Doxorubicin—lung cancer	3.08e-05	0.00013	CcSEcCtD
Fentanyl—Headache—Paclitaxel—lung cancer	3.07e-05	0.00013	CcSEcCtD
Fentanyl—Hypersensitivity—Docetaxel—lung cancer	3.06e-05	0.00013	CcSEcCtD
Fentanyl—Muscle spasms—Doxorubicin—lung cancer	3.06e-05	0.00013	CcSEcCtD
Fentanyl—Confusional state—Methotrexate—lung cancer	3.02e-05	0.000128	CcSEcCtD
Fentanyl—Anaphylactic shock—Methotrexate—lung cancer	3e-05	0.000127	CcSEcCtD
Fentanyl—Vision blurred—Doxorubicin—lung cancer	3e-05	0.000127	CcSEcCtD
Fentanyl—Asthenia—Docetaxel—lung cancer	2.98e-05	0.000127	CcSEcCtD
Fentanyl—Infection—Methotrexate—lung cancer	2.98e-05	0.000126	CcSEcCtD
Fentanyl—Nausea—Etoposide—lung cancer	2.97e-05	0.000126	CcSEcCtD
Fentanyl—Ill-defined disorder—Doxorubicin—lung cancer	2.95e-05	0.000125	CcSEcCtD
Fentanyl—Pruritus—Docetaxel—lung cancer	2.94e-05	0.000125	CcSEcCtD
Fentanyl—Nervous system disorder—Methotrexate—lung cancer	2.94e-05	0.000125	CcSEcCtD
Fentanyl—Anaemia—Doxorubicin—lung cancer	2.94e-05	0.000125	CcSEcCtD
Fentanyl—Thrombocytopenia—Methotrexate—lung cancer	2.94e-05	0.000124	CcSEcCtD
Fentanyl—Agitation—Doxorubicin—lung cancer	2.92e-05	0.000124	CcSEcCtD
Fentanyl—Nausea—Paclitaxel—lung cancer	2.92e-05	0.000124	CcSEcCtD
Fentanyl—Skin disorder—Methotrexate—lung cancer	2.91e-05	0.000123	CcSEcCtD
Fentanyl—Hyperhidrosis—Methotrexate—lung cancer	2.9e-05	0.000123	CcSEcCtD
Fentanyl—Malaise—Doxorubicin—lung cancer	2.87e-05	0.000122	CcSEcCtD
Fentanyl—Vertigo—Doxorubicin—lung cancer	2.86e-05	0.000121	CcSEcCtD
Fentanyl—Anorexia—Methotrexate—lung cancer	2.86e-05	0.000121	CcSEcCtD
Fentanyl—Syncope—Doxorubicin—lung cancer	2.85e-05	0.000121	CcSEcCtD
Fentanyl—Leukopenia—Doxorubicin—lung cancer	2.85e-05	0.000121	CcSEcCtD
Fentanyl—Diarrhoea—Docetaxel—lung cancer	2.85e-05	0.000121	CcSEcCtD
Fentanyl—Palpitations—Doxorubicin—lung cancer	2.81e-05	0.000119	CcSEcCtD
Fentanyl—Hypotension—Methotrexate—lung cancer	2.8e-05	0.000119	CcSEcCtD
Fentanyl—Loss of consciousness—Doxorubicin—lung cancer	2.8e-05	0.000119	CcSEcCtD
Fentanyl—Cough—Doxorubicin—lung cancer	2.78e-05	0.000118	CcSEcCtD
Fentanyl—Convulsion—Doxorubicin—lung cancer	2.76e-05	0.000117	CcSEcCtD
Fentanyl—Dizziness—Docetaxel—lung cancer	2.75e-05	0.000117	CcSEcCtD
Fentanyl—Hypertension—Doxorubicin—lung cancer	2.75e-05	0.000116	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methotrexate—lung cancer	2.73e-05	0.000116	CcSEcCtD
Fentanyl—Insomnia—Methotrexate—lung cancer	2.71e-05	0.000115	CcSEcCtD
Fentanyl—Arthralgia—Doxorubicin—lung cancer	2.71e-05	0.000115	CcSEcCtD
Fentanyl—Myalgia—Doxorubicin—lung cancer	2.71e-05	0.000115	CcSEcCtD
Fentanyl—Chest pain—Doxorubicin—lung cancer	2.71e-05	0.000115	CcSEcCtD
Fentanyl—Anxiety—Doxorubicin—lung cancer	2.7e-05	0.000114	CcSEcCtD
Fentanyl—Paraesthesia—Methotrexate—lung cancer	2.69e-05	0.000114	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.69e-05	0.000114	CcSEcCtD
Fentanyl—Discomfort—Doxorubicin—lung cancer	2.68e-05	0.000113	CcSEcCtD
Fentanyl—Dyspnoea—Methotrexate—lung cancer	2.67e-05	0.000113	CcSEcCtD
Fentanyl—Somnolence—Methotrexate—lung cancer	2.67e-05	0.000113	CcSEcCtD
Fentanyl—Dry mouth—Doxorubicin—lung cancer	2.65e-05	0.000112	CcSEcCtD
Fentanyl—Vomiting—Docetaxel—lung cancer	2.64e-05	0.000112	CcSEcCtD
Fentanyl—Dyspepsia—Methotrexate—lung cancer	2.64e-05	0.000112	CcSEcCtD
Fentanyl—Rash—Docetaxel—lung cancer	2.62e-05	0.000111	CcSEcCtD
Fentanyl—Dermatitis—Docetaxel—lung cancer	2.62e-05	0.000111	CcSEcCtD
Fentanyl—Confusional state—Doxorubicin—lung cancer	2.62e-05	0.000111	CcSEcCtD
Fentanyl—Decreased appetite—Methotrexate—lung cancer	2.61e-05	0.000111	CcSEcCtD
Fentanyl—Headache—Docetaxel—lung cancer	2.61e-05	0.000111	CcSEcCtD
Fentanyl—Anaphylactic shock—Doxorubicin—lung cancer	2.6e-05	0.00011	CcSEcCtD
Fentanyl—Oedema—Doxorubicin—lung cancer	2.6e-05	0.00011	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Methotrexate—lung cancer	2.59e-05	0.00011	CcSEcCtD
Fentanyl—Fatigue—Methotrexate—lung cancer	2.58e-05	0.00011	CcSEcCtD
Fentanyl—Infection—Doxorubicin—lung cancer	2.58e-05	0.000109	CcSEcCtD
Fentanyl—Pain—Methotrexate—lung cancer	2.56e-05	0.000109	CcSEcCtD
Fentanyl—Shock—Doxorubicin—lung cancer	2.55e-05	0.000108	CcSEcCtD
Fentanyl—Nervous system disorder—Doxorubicin—lung cancer	2.55e-05	0.000108	CcSEcCtD
Fentanyl—Thrombocytopenia—Doxorubicin—lung cancer	2.54e-05	0.000108	CcSEcCtD
Fentanyl—Tachycardia—Doxorubicin—lung cancer	2.53e-05	0.000107	CcSEcCtD
Fentanyl—Skin disorder—Doxorubicin—lung cancer	2.52e-05	0.000107	CcSEcCtD
Fentanyl—Hyperhidrosis—Doxorubicin—lung cancer	2.51e-05	0.000106	CcSEcCtD
Fentanyl—Anorexia—Doxorubicin—lung cancer	2.47e-05	0.000105	CcSEcCtD
Fentanyl—Nausea—Docetaxel—lung cancer	2.47e-05	0.000105	CcSEcCtD
Fentanyl—Feeling abnormal—Methotrexate—lung cancer	2.47e-05	0.000105	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methotrexate—lung cancer	2.45e-05	0.000104	CcSEcCtD
Fentanyl—Hypotension—Doxorubicin—lung cancer	2.43e-05	0.000103	CcSEcCtD
Fentanyl—Urticaria—Methotrexate—lung cancer	2.38e-05	0.000101	CcSEcCtD
Fentanyl—Body temperature increased—Methotrexate—lung cancer	2.37e-05	0.000101	CcSEcCtD
Fentanyl—Abdominal pain—Methotrexate—lung cancer	2.37e-05	0.000101	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.37e-05	0.0001	CcSEcCtD
Fentanyl—Insomnia—Doxorubicin—lung cancer	2.35e-05	9.96e-05	CcSEcCtD
Fentanyl—Paraesthesia—Doxorubicin—lung cancer	2.33e-05	9.89e-05	CcSEcCtD
Fentanyl—Dyspnoea—Doxorubicin—lung cancer	2.31e-05	9.81e-05	CcSEcCtD
Fentanyl—Somnolence—Doxorubicin—lung cancer	2.31e-05	9.79e-05	CcSEcCtD
Fentanyl—Dyspepsia—Doxorubicin—lung cancer	2.29e-05	9.69e-05	CcSEcCtD
Fentanyl—Decreased appetite—Doxorubicin—lung cancer	2.26e-05	9.57e-05	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Doxorubicin—lung cancer	2.24e-05	9.5e-05	CcSEcCtD
Fentanyl—Fatigue—Doxorubicin—lung cancer	2.24e-05	9.49e-05	CcSEcCtD
Fentanyl—Pain—Doxorubicin—lung cancer	2.22e-05	9.41e-05	CcSEcCtD
Fentanyl—Constipation—Doxorubicin—lung cancer	2.22e-05	9.41e-05	CcSEcCtD
Fentanyl—Hypersensitivity—Methotrexate—lung cancer	2.21e-05	9.37e-05	CcSEcCtD
Fentanyl—Asthenia—Methotrexate—lung cancer	2.15e-05	9.12e-05	CcSEcCtD
Fentanyl—Feeling abnormal—Doxorubicin—lung cancer	2.14e-05	9.07e-05	CcSEcCtD
Fentanyl—Gastrointestinal pain—Doxorubicin—lung cancer	2.12e-05	9e-05	CcSEcCtD
Fentanyl—Pruritus—Methotrexate—lung cancer	2.12e-05	8.99e-05	CcSEcCtD
Fentanyl—Urticaria—Doxorubicin—lung cancer	2.06e-05	8.75e-05	CcSEcCtD
Fentanyl—Body temperature increased—Doxorubicin—lung cancer	2.05e-05	8.7e-05	CcSEcCtD
Fentanyl—Abdominal pain—Doxorubicin—lung cancer	2.05e-05	8.7e-05	CcSEcCtD
Fentanyl—Diarrhoea—Methotrexate—lung cancer	2.05e-05	8.7e-05	CcSEcCtD
Fentanyl—Dizziness—Methotrexate—lung cancer	1.98e-05	8.41e-05	CcSEcCtD
Fentanyl—Hypersensitivity—Doxorubicin—lung cancer	1.91e-05	8.11e-05	CcSEcCtD
Fentanyl—Vomiting—Methotrexate—lung cancer	1.91e-05	8.08e-05	CcSEcCtD
Fentanyl—Rash—Methotrexate—lung cancer	1.89e-05	8.02e-05	CcSEcCtD
Fentanyl—Dermatitis—Methotrexate—lung cancer	1.89e-05	8.01e-05	CcSEcCtD
Fentanyl—Headache—Methotrexate—lung cancer	1.88e-05	7.96e-05	CcSEcCtD
Fentanyl—Asthenia—Doxorubicin—lung cancer	1.86e-05	7.9e-05	CcSEcCtD
Fentanyl—Pruritus—Doxorubicin—lung cancer	1.84e-05	7.79e-05	CcSEcCtD
Fentanyl—Nausea—Methotrexate—lung cancer	1.78e-05	7.55e-05	CcSEcCtD
Fentanyl—Diarrhoea—Doxorubicin—lung cancer	1.78e-05	7.53e-05	CcSEcCtD
Fentanyl—Dizziness—Doxorubicin—lung cancer	1.72e-05	7.28e-05	CcSEcCtD
Fentanyl—Vomiting—Doxorubicin—lung cancer	1.65e-05	7e-05	CcSEcCtD
Fentanyl—Rash—Doxorubicin—lung cancer	1.64e-05	6.94e-05	CcSEcCtD
Fentanyl—Dermatitis—Doxorubicin—lung cancer	1.64e-05	6.93e-05	CcSEcCtD
Fentanyl—Headache—Doxorubicin—lung cancer	1.63e-05	6.9e-05	CcSEcCtD
Fentanyl—Nausea—Doxorubicin—lung cancer	1.54e-05	6.54e-05	CcSEcCtD
Fentanyl—ABCB1—Metabolism—ADCY1—lung cancer	9.38e-06	0.000166	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ABCG2—lung cancer	9.38e-06	0.000166	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCL8—lung cancer	9.38e-06	0.000166	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2A7—lung cancer	9.36e-06	0.000166	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ERBB3—lung cancer	9.32e-06	0.000165	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—EGFR—lung cancer	9.25e-06	0.000164	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HPGDS—lung cancer	9.2e-06	0.000163	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ENO2—lung cancer	9.2e-06	0.000163	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SDC4—lung cancer	9.16e-06	0.000162	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPP2R1B—lung cancer	9.14e-06	0.000162	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAP2K1—lung cancer	8.98e-06	0.000159	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL2—lung cancer	8.96e-06	0.000159	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TERT—lung cancer	8.93e-06	0.000158	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CD—lung cancer	8.92e-06	0.000158	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTT1—lung cancer	8.92e-06	0.000158	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CG—lung cancer	8.9e-06	0.000158	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KIT—lung cancer	8.9e-06	0.000158	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APC—lung cancer	8.9e-06	0.000158	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—NRAS—lung cancer	8.9e-06	0.000158	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—STK11—lung cancer	8.86e-06	0.000157	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PIK3CA—lung cancer	8.84e-06	0.000157	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GCLC—lung cancer	8.82e-06	0.000156	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP2A6—lung cancer	8.82e-06	0.000156	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGF—lung cancer	8.8e-06	0.000156	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—KRAS—lung cancer	8.74e-06	0.000155	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FGFR1—lung cancer	8.67e-06	0.000154	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	8.66e-06	0.000153	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HIF1A—lung cancer	8.54e-06	0.000151	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—MAPK3—lung cancer	8.52e-06	0.000151	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOA1—lung cancer	8.48e-06	0.00015	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—POMC—lung cancer	8.47e-06	0.00015	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—BRAF—lung cancer	8.37e-06	0.000148	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ENO1—lung cancer	8.36e-06	0.000148	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	8.35e-06	0.000148	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTA3—lung cancer	8.34e-06	0.000148	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—RRM1—lung cancer	8.34e-06	0.000148	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6R—lung cancer	8.27e-06	0.000146	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CREBBP—lung cancer	8.25e-06	0.000146	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOA1—lung cancer	8.24e-06	0.000146	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTP1—lung cancer	8.2e-06	0.000145	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KDR—lung cancer	8.17e-06	0.000145	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—EGFR—lung cancer	8.11e-06	0.000144	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CA—lung cancer	8.03e-06	0.000142	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MDM2—lung cancer	7.99e-06	0.000142	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CAT—lung cancer	7.98e-06	0.000141	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RAF1—lung cancer	7.97e-06	0.000141	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ERBB2—lung cancer	7.88e-06	0.00014	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAP2K1—lung cancer	7.88e-06	0.000139	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—B4GALT5—lung cancer	7.84e-06	0.000139	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CD—lung cancer	7.82e-06	0.000139	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	7.82e-06	0.000138	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MTOR—lung cancer	7.78e-06	0.000138	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CB—lung cancer	7.78e-06	0.000138	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ABCB1—lung cancer	7.76e-06	0.000137	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CA—lung cancer	7.75e-06	0.000137	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CG—lung cancer	7.74e-06	0.000137	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—KRAS—lung cancer	7.66e-06	0.000136	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTA4—lung cancer	7.63e-06	0.000135	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—TYMS—lung cancer	7.62e-06	0.000135	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTM1—lung cancer	7.53e-06	0.000133	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CG—lung cancer	7.52e-06	0.000133	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KIT—lung cancer	7.52e-06	0.000133	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APC—lung cancer	7.52e-06	0.000133	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—NRAS—lung cancer	7.52e-06	0.000133	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP2E1—lung cancer	7.5e-06	0.000133	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL8—lung cancer	7.47e-06	0.000132	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGF—lung cancer	7.44e-06	0.000132	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTA2—lung cancer	7.43e-06	0.000132	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HRAS—lung cancer	7.43e-06	0.000131	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NQO1—lung cancer	7.42e-06	0.000131	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—POMC—lung cancer	7.37e-06	0.00013	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—AKT1—lung cancer	7.22e-06	0.000128	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—MAPK3—lung cancer	7.2e-06	0.000128	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CREBBP—lung cancer	7.17e-06	0.000127	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTA1—lung cancer	7.17e-06	0.000127	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—POMC—lung cancer	7.16e-06	0.000127	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CASP3—lung cancer	7.15e-06	0.000127	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL2—lung cancer	7.14e-06	0.000126	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP1A1—lung cancer	7.14e-06	0.000126	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—lung cancer	7.11e-06	0.000126	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCC3—lung cancer	7.09e-06	0.000126	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ERCC2—lung cancer	7.08e-06	0.000125	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	7.07e-06	0.000125	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—BRAF—lung cancer	7.07e-06	0.000125	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CA—lung cancer	7.04e-06	0.000125	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MDM2—lung cancer	7.01e-06	0.000124	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RAF1—lung cancer	6.99e-06	0.000124	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6R—lung cancer	6.99e-06	0.000124	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CREBBP—lung cancer	6.97e-06	0.000123	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCND1—lung cancer	6.96e-06	0.000123	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—JUN—lung cancer	6.95e-06	0.000123	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ERBB2—lung cancer	6.91e-06	0.000122	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKR1C1—lung cancer	6.87e-06	0.000122	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EGFR—lung cancer	6.85e-06	0.000121	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MTOR—lung cancer	6.82e-06	0.000121	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CB—lung cancer	6.82e-06	0.000121	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CD—lung cancer	6.8e-06	0.00012	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—lung cancer	6.76e-06	0.00012	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CDKN1A—lung cancer	6.74e-06	0.000119	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PTEN—lung cancer	6.72e-06	0.000119	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALB—lung cancer	6.71e-06	0.000119	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—STK11—lung cancer	6.68e-06	0.000118	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—UGT1A1—lung cancer	6.67e-06	0.000118	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAP2K1—lung cancer	6.66e-06	0.000118	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CD—lung cancer	6.61e-06	0.000117	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—AKT1—lung cancer	6.56e-06	0.000116	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL8—lung cancer	6.55e-06	0.000116	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	6.55e-06	0.000116	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HRAS—lung cancer	6.51e-06	0.000115	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—KRAS—lung cancer	6.47e-06	0.000115	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GNG11—lung cancer	6.43e-06	0.000114	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EP300—lung cancer	6.41e-06	0.000113	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—AKT1—lung cancer	6.33e-06	0.000112	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CASP3—lung cancer	6.27e-06	0.000111	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL2—lung cancer	6.26e-06	0.000111	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SRC—lung cancer	6.23e-06	0.00011	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—lung cancer	6.23e-06	0.00011	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTP1—lung cancer	6.19e-06	0.00011	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOA1—lung cancer	6.13e-06	0.000108	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALDOA—lung cancer	6.12e-06	0.000108	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCND1—lung cancer	6.11e-06	0.000108	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—JUN—lung cancer	6.09e-06	0.000108	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—lung cancer	6.07e-06	0.000107	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CAT—lung cancer	6.02e-06	0.000107	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STAT3—lung cancer	6.01e-06	0.000106	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NRAS—lung cancer	6e-06	0.000106	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	5.95e-06	0.000105	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NCOA3—lung cancer	5.94e-06	0.000105	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CB—lung cancer	5.93e-06	0.000105	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—lung cancer	5.93e-06	0.000105	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MDM2—lung cancer	5.92e-06	0.000105	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CDKN1A—lung cancer	5.91e-06	0.000105	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RAF1—lung cancer	5.9e-06	0.000105	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTEN—lung cancer	5.89e-06	0.000104	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—lung cancer	5.87e-06	0.000104	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ERBB2—lung cancer	5.84e-06	0.000103	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCG2—lung cancer	5.78e-06	0.000102	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ADCY1—lung cancer	5.78e-06	0.000102	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MTOR—lung cancer	5.76e-06	0.000102	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CB—lung cancer	5.76e-06	0.000102	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TYMS—lung cancer	5.75e-06	0.000102	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—AKT1—lung cancer	5.75e-06	0.000102	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK3—lung cancer	5.74e-06	0.000102	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTM1—lung cancer	5.68e-06	0.000101	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ENO2—lung cancer	5.67e-06	0.0001	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HPGDS—lung cancer	5.67e-06	0.0001	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.63e-06	9.97e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EP300—lung cancer	5.62e-06	9.95e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CG—lung cancer	5.59e-06	9.9e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MYC—lung cancer	5.59e-06	9.89e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL8—lung cancer	5.54e-06	9.81e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HRAS—lung cancer	5.5e-06	9.74e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTT1—lung cancer	5.5e-06	9.73e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SRC—lung cancer	5.47e-06	9.68e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGFR—lung cancer	5.46e-06	9.67e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GCLC—lung cancer	5.43e-06	9.62e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2A6—lung cancer	5.43e-06	9.62e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP1A1—lung cancer	5.39e-06	9.54e-05	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT1—lung cancer	5.35e-06	9.48e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ERCC2—lung cancer	5.34e-06	9.46e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—POMC—lung cancer	5.32e-06	9.43e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—lung cancer	5.32e-06	9.43e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CASP3—lung cancer	5.3e-06	9.39e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL2—lung cancer	5.29e-06	9.37e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STAT3—lung cancer	5.27e-06	9.33e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—lung cancer	5.27e-06	9.33e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NRAS—lung cancer	5.26e-06	9.31e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CREBBP—lung cancer	5.19e-06	9.18e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KRAS—lung cancer	5.16e-06	9.14e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCND1—lung cancer	5.16e-06	9.14e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ENO1—lung cancer	5.15e-06	9.12e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—JUN—lung cancer	5.15e-06	9.12e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTEN—lung cancer	5.12e-06	9.07e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK3—lung cancer	5.04e-06	8.92e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—lung cancer	5.01e-06	8.87e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CDKN1A—lung cancer	4.99e-06	8.84e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTEN—lung cancer	4.98e-06	8.82e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CD—lung cancer	4.92e-06	8.71e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MYC—lung cancer	4.9e-06	8.67e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—EP300—lung cancer	4.89e-06	8.65e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT1—lung cancer	4.86e-06	8.6e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALB—lung cancer	4.85e-06	8.59e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGFR—lung cancer	4.79e-06	8.48e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EP300—lung cancer	4.75e-06	8.41e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CA—lung cancer	4.74e-06	8.4e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOA1—lung cancer	4.62e-06	8.19e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2E1—lung cancer	4.62e-06	8.18e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SRC—lung cancer	4.62e-06	8.18e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—lung cancer	4.59e-06	8.12e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NQO1—lung cancer	4.57e-06	8.09e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KRAS—lung cancer	4.53e-06	8.01e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—lung cancer	4.5e-06	7.97e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STAT3—lung cancer	4.45e-06	7.89e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NRAS—lung cancer	4.44e-06	7.87e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HRAS—lung cancer	4.39e-06	7.77e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CB—lung cancer	4.29e-06	7.59e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK3—lung cancer	4.26e-06	7.54e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—lung cancer	4.25e-06	7.52e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CG—lung cancer	4.22e-06	7.47e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—lung cancer	4.2e-06	7.43e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CA—lung cancer	4.16e-06	7.36e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MYC—lung cancer	4.14e-06	7.33e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—STK11—lung cancer	4.12e-06	7.29e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGFR—lung cancer	4.05e-06	7.17e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—lung cancer	4.02e-06	7.12e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—POMC—lung cancer	4.02e-06	7.11e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CREBBP—lung cancer	3.91e-06	6.93e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT1—lung cancer	3.87e-06	6.86e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HRAS—lung cancer	3.85e-06	6.81e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KRAS—lung cancer	3.82e-06	6.77e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTP1—lung cancer	3.81e-06	6.75e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CD—lung cancer	3.71e-06	6.57e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CAT—lung cancer	3.71e-06	6.57e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTEN—lung cancer	3.7e-06	6.56e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—lung cancer	3.68e-06	6.52e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALB—lung cancer	3.66e-06	6.49e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CA—lung cancer	3.61e-06	6.4e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCB1—lung cancer	3.61e-06	6.39e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TYMS—lung cancer	3.54e-06	6.27e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—EP300—lung cancer	3.53e-06	6.25e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CA—lung cancer	3.51e-06	6.22e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTM1—lung cancer	3.5e-06	6.2e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—lung cancer	3.4e-06	6.02e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT1—lung cancer	3.4e-06	6.01e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP1A1—lung cancer	3.32e-06	5.88e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ERCC2—lung cancer	3.29e-06	5.83e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HRAS—lung cancer	3.25e-06	5.76e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CB—lung cancer	3.23e-06	5.73e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—lung cancer	3.2e-06	5.67e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—lung cancer	3.11e-06	5.51e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKT1—lung cancer	2.95e-06	5.23e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT1—lung cancer	2.87e-06	5.08e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOA1—lung cancer	2.85e-06	5.04e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTEN—lung cancer	2.79e-06	4.95e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—EP300—lung cancer	2.67e-06	4.72e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CA—lung cancer	2.61e-06	4.63e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CG—lung cancer	2.6e-06	4.6e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—POMC—lung cancer	2.48e-06	4.38e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CREBBP—lung cancer	2.41e-06	4.27e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CD—lung cancer	2.29e-06	4.05e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALB—lung cancer	2.26e-06	4e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKT1—lung cancer	2.13e-06	3.78e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CB—lung cancer	1.99e-06	3.53e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—lung cancer	1.97e-06	3.5e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CA—lung cancer	1.97e-06	3.49e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTEN—lung cancer	1.72e-06	3.05e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—EP300—lung cancer	1.64e-06	2.91e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKT1—lung cancer	1.61e-06	2.85e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CA—lung cancer	1.21e-06	2.15e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKT1—lung cancer	9.92e-07	1.76e-05	CbGpPWpGaD
